Archives
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-05-26
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides a reliable SDS-PAGE and Western blot molecular weight standard, specifically designed to support workflows requiring clear, multi-color band visualization and EDTA-free compatibility. Suitable for routine and specialized applications—including phosphoprotein detection and fluorescent membrane imaging—it should not be used where unlabelled or non-protein molecular weight references are required.
-
Peroxidasin Drives Glycolytic Malignancy in Glioblastoma via
2026-05-25
This study identifies peroxidasin (PXDN) as a central modulator of glycolytic metabolism in glioblastoma, operating through the regulation of lactate dehydrogenase A (LDHA). Functionally, PXDN promotes tumor progression by enhancing glycolytic flux, positioning it as a promising diagnostic marker and therapeutic target in GBM.
-
Orientia tsutsugamushi’s Modulation of RIPK3 Without Blockin
2026-05-25
This study uncovers how Orientia tsutsugamushi, the agent of scrub typhus, lowers cellular RIPK3 but does not inhibit necroptosis in host cells. These findings clarify the bacterium’s evasion of programmed cell death and have implications for understanding host-pathogen interactions and cell death pathway research.
-
GM 6001 (Galardin): Rethinking MMP Inhibition for Translatio
2026-05-24
Discover how GM 6001 (Galardin) is reshaping the landscape of matrix metalloproteinase research, empowering translational scientists with new mechanistic tools to interrogate extracellular matrix dynamics, disease progression, and innovative therapeutic strategies. This thought-leadership article blends deep mechanistic insight with actionable protocol advice for researchers at the front lines of tissue remodeling, neurodegeneration, cancer, and vascular biology.
-
Batimastat (BB-94) in MMP-Driven BDNF and Tumor Research
2026-05-23
Batimastat (BB-94) delivers precision MMP inhibition for dissecting neurotrophic processing and tumor microenvironment dynamics. Its robust potency, high DMSO solubility, and proven in vitro/in vivo versatility set it apart for advanced synaptic and cancer workflows.
-
Vasopressin Analogues: Advances in Therapeutics and Mechanis
2026-05-22
The reviewed study systematically explores vasopressin and its analogues, emphasizing the biochemical innovation and translational impact of natural and synthetic derivatives such as lypressin acetate. The findings clarify how subtle sequence changes modulate pharmacological profiles, enabling new therapeutic strategies for diabetes insipidus and emerging antiviral research.
-
Preserving Phosphorylation: Precision Tools for Translationa
2026-05-22
This article explores the essential role of phosphorylation state preservation in translational research, the mechanistic rationale for robust phosphatase inhibition, and the strategic integration of Phosphatase Inhibitor Cocktail 1 (100X in DMSO) in advanced workflows. Drawing from recent advances in cancer signaling and phosphoproteomics, it guides researchers on best practices and future directions.
-
Biomimetic Chromatography for Modeling Pulmonary Drug Permea
2026-05-21
The referenced study introduces and rigorously compares two biomimetic chromatographic techniques, IAM-LC and OT-CEC, each coupled with mass spectrometry, for modeling and predicting pulmonary permeability of diverse pharmaceuticals. These high-throughput, MS-compatible methods advance the precision of early-stage drug permeability profiling, supporting rational lead optimization in antiretroviral and cancer research.
-
Cell-to-Cell Transfer of Immunoproteasomes via Extracellular
2026-05-21
This study demonstrates that non-constitutive proteasomes, including immunoproteasomes, can be transmitted between cells through extracellular vesicles, a previously unproven mechanism. The findings have implications for immune modulation, antigen presentation, and the design of future studies employing selective immunoproteasome inhibitors.
-
MLN2238: Proteasome β5 Subunit Inhibitor for Translational O
2026-05-20
MLN2238 sets a new benchmark in proteasome β5 subunit inhibition, enabling robust apoptosis induction, NF-κB suppression, and resistance-overcoming workflows in multiple myeloma and lymphoma research. This article delivers actionable protocols, troubleshooting guidance, and advanced applications, leveraging insights from cutting-edge CREB/CRTC stress response pathways.
-
Asunaprevir (BMS-650032): Unraveling Host-Pathogen Interplay
2026-05-20
Explore how Asunaprevir (BMS-650032) enables advanced studies of HCV RNA replication inhibition and sheds light on host-pathogen signaling crosstalk. This cornerstone article offers a unique systems biology perspective, distinct from standard reviews, for researchers leveraging APExBIO’s compound in antiviral and mechanistic workflows.
-
MLN2238: Precision Proteasome β5 Subunit Inhibitor Workflows
2026-05-19
MLN2238 delivers nanomolar precision and robust apoptosis induction for oncology research, outperforming legacy proteasome β5 subunit inhibitors even in bortezomib-resistant contexts. This guide details optimized workflows, troubleshooting, and advanced applications, translating the latest mechanistic insights into bench-ready protocols.
-
Calpain Inhibitor I, ALLN: Practical Use in Apoptosis & Inju
2026-05-19
Calpain Inhibitor I, ALLN (SKU A2602) is a potent inhibitor for calpain I/II and cathepsin B/L, supporting precise modulation of cysteine protease activity in apoptosis and ischemia-reperfusion injury models. It is suited for mechanistic research workflows where selectivity, solubility, and reproducibility are critical. This compound is not intended for diagnostic or clinical applications, and its use outside of supported research contexts is not recommended.
-
FAPα-Responsive Nanoparticle Probes for Solid Tumor Detectio
2026-05-18
Feng et al. present a novel diagnostic approach using magnetic nanoparticles coated with FAPα-sensitive synthetic urinary probes, enabling noninvasive and highly accurate detection of FAPα-expressing solid tumors. This work highlights the potential of extracellular protease-activated biomarkers for tumor microenvironment characterization and early cancer diagnosis.
-
Cell lysis buffer for WB and IP: Precision Protein Extractio
2026-05-18
Unlock robust, non-denaturing protein extraction from animal, plant, and microbial sources using Cell lysis buffer for WB and IP. This APExBIO solution streamlines Western blot, immunoprecipitation, and co-IP workflows by integrating a powerful protease and phosphatase inhibitor cocktail, ensuring reproducible results while preserving labile signaling complexes.